Wire · opportunities
Aptitude Announces FDA 510(k) Clearance of Next-Generation Metrix® COVID Test
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 17 September 2026 · Fusion42 review
Aptitude Medical Systems received FDA 510(k) clearance for its next-generation Metrix COVID Test, offering improved sensitivity and faster results. This marks a transition from emergency authorization to traditional FDA clearance as the company expands its molecular diagnostics platform with additional respiratory and STI tests.
This Wire brief sits within Fusion42's coverage of Medtech, and 5 sources have reported it between 16 Sep 2026 and 18 Sep 2026.
◆ ◆ The Wire takeaway
You face a clearer regulatory path as emergency use authorizations expire at end-2026, making established FDA 510(k) clearances essential to remain in respiratory diagnostics markets. This clearance opens doors to urgent care clinics where Metrix's smaller, faster test fits unmet needs.
◆ Coverage
5 sources · first reported 16 Sep 2026 · latest 18 Sep 2026
◆ Related on Wire
◆ Topics